IP Library › Granted Patent US 7,220,748
Granted Patent B2
US 7,220,748 · App. 10/502,827 · Granted May 22, 2007

Use of 4-(2-Flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-D)-pyrimidine for treating of urinary incontinence

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,220,748
App. No.
10/502,827
Granted
May 22, 2007
Kind
B2
Abstract

4-(2-Fluorophenyl)-6-Methyl-2-(1-Piperazinyl)-Thieno(2,3-D)pyrimidine or a salt thereof is useful for the treatment of urinary incontinence.

Claims (3)

1. A method for treating urinary incontinence wherein said method comprises administering, to a patient in need of such treatment, an effective amount of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine or a salt thereof.

2. The method, according to claim 1 , wherein the salt is the monohydrate hydrochloride.

3. The method, according to claim 1 , wherein the urinary incontinence is stress urinary incontinence.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2010
From: DYNOGEN PHARMACEUTICALS, INC.
To: EDUSA PHARMACEUTICALS, INC.
Reel/Frame 024879/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2008
From: ARACHNOVA THERAPEUTICS LIMITED
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 020409/0077 →
SECURITY AGREEMENT Recorded Jan 3, 2008
From: DYNOGEN PHARMACEUTICALS, INC.
To: ARACHNOVA THERAPEUTICS LIMITED
Reel/Frame 020309/0537 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2005
From: ARACHNOVA LTD.
To: ARACHNOVA THERAPEUTICS LTD.
Reel/Frame 016517/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2004
From: CAVALLA, DAVID; GRISTWOOD, ROBERT WILLIAM
To: ARACHNOVA LTD.
Reel/Frame 015210/0668 →